TBI remained significantly associated with reduced adjusted risks of grade 3 to 4 aGVHD and moderate-severe cGVHD.

Sergio A. Giralt, MD, discusses how he uses cyclophosphamide to treat patients with chronic graft-vs-host disease (cGVHD), particularly in specific cases where other therapies may not be effective.

Sergio A. Giralt, MD, discusses how he selects patients with chronic graft-vs-host disease (cGVHD) for treatment with ruxolitinib, often in combination with corticosteroids, and reviews the study ...

These findings warrant further exploration into the mechanisms by which SDF-1α contributes to AML pathophysiology and treatment outcomes. Moreover, prospective clinical trials are needed to validate ...

Collectively, array studies have identified new clonal deletions and amplifications that probably contribute to disease pathogenesis ... and less progression to AML (p = 0.033) [11] Graubert ...

As Canada’s second-largest lender digs into the AML remediation work it must do to satisfy regulators who hit the bank with $3.09 billion in fines, TD has shelved growth targets and embarked on a ...

In one of the most prominent embezzlement cases ever, Malaysian financier Jho Low allegedly siphoned billions from the 1MDB fund, using citizenship by investment (CBI) programs to secure multiple ...